Studiul urmareste evaluarea eficacitatii, sigurantei si tolerabilitatii administrarii ponesimod la pacientii cu scleroza multipla.

Titlu Studiu

Multicenter, Non-comparative Extension to Study AC-058B301, to Investigate the Long-term Safety, Tolerability, and Control of Disease of Ponesimod 20 mg in Subjects With Relapsing Multiple Sclerosis

Cod protocol: AC-058B303

Numar EudraCT: 2016-005020-29

Sponsor: Novartis Pharmaceuticals

Medicament de investigatie clinica: Ponesimod

Medicament de investigatie clinica comparator: nu

Placebo: nu

International/National: international

Faza: III

Centre România

COUNTY CLIN EMERGENCY HOSP – II NEUROLOGY (Timisoara), Timisoara, Romania, 300723